SCHEMBL25568690

SCHEMBL25568690

COCCCn1nccc1C(=O)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 4/20 0.39
KDR P35968 4/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MAPK1 P28482 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
CCNE1 P24864 2/20 0.37
CDK2 P24941 2/20 0.37
GSK3B P49841 2/20 0.37
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
KDM4E B2RXH2 1/20 0.35
APAF1 O14727 1/20 0.35
USP2 O75604 1/20 0.35
NSD2 O96028 1/20 0.35
LMNA P02545 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25457943 0.84 MAPK1 (0.41) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL24103210 0.84 MAPK1 (0.41) FLT1KDRMAPK1L3MBTL1ALDH1A1
SCHEMBL30420580 0.82 FLT1 (0.43) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL29531419 0.81 L3MBTL1 (0.43) FLT1KDRNPC1RAB9AL3MBTL1
SCHEMBL25522136 0.80 MAPK1 (0.42) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL29530824 0.80 KMT2A (0.37) FLT1KDRMAPK1L3MBTL1CCNE1
SCHEMBL25564519 0.80 FLT1 (0.39) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL29530662 0.79 HPGD (0.48) FLT1KDRRAB9AMAPK1L3MBTL1
SCHEMBL24103203 0.79 ALDH1A1 (0.43) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL17452804 0.77 RAB9A (0.50) FLT1KDRNPC1RAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159465-A1 IMMUNOMODULATOR HITGEN INC. (CN) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159465-A1 IMMUNOMODULATOR IL2, IL17A, IL2RA FLT1 2561/4885KDR 3968/4885NPC1 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.